Mirena

Mirena is a brand name of levonorgestrel, approved by the FDA in the following formulation(s):

MIRENA (levonorgestrel - intrauterine device; intrauterine)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approval date: December 6, 2000
  
  Strength(s): 52MG ^[RLD]

Has a generic version of Mirena been approved?

No. There is currently no therapeutically equivalent version of Mirena available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mirena. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Inserter for the positioning of an intrauterine device
  Patent 5,785,053
  Issued: July 28, 1998
  Inventor(s): Macandrew; John & Conway; John & Paton; Michael & Gardner; Richard & Rauramo; Ilkka & Lehtinen; Matti
  Assignee(s): Leiras Oy
  An inserter for the positioning of an intrauterine device in the uterus, which inserter includes a plunger, a handle attached to the plunger, a string for the removal of the IUD, a locking device to lock the string in such a way that the IUD remains immobile in relation to the plunger, and a protective tube around the plunger. The protective tube is arranged in relation to the plunger in such a way that it can be pushed, at the forward end that goes into the uterus, past the plunger at distance (L) , which corresponds substantially to the length of the IUD assembled for insertion. The stop members ensure that the front edge of the protective tube is stopped in a configuration in which the hemispherical tips of the wings of the transverse member of a T-shaped IUD remain partly uncovered by the protective tube, but the wings nevertheless remain pressed against each other.
  
  Patent expiration dates:
  
  
  • December 5, 2015
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 1, 2012 - TREATMENT OF HEAVY MENSTRUAL BLEEDING FOR WOMEN WHO CHOOSE TO USE INTRAUTERINE CONTRACEPTION AS THEIR METHOD OF CONTRACEPTION
  
  

See also...

• Mirena Consumer Information (Drugs.com)
• Mirena IUD Consumer Information (Wolters Kluwer)
• Mirena Consumer Information (Cerner Multum)
• Mirena Advanced Consumer Information (Micromedex)
• Levonorgestrel Consumer Information (Wolters Kluwer)
• Levonorgestrel IUD Consumer Information (Wolters Kluwer)
• Levonorgestrel Consumer Information (Cerner Multum)
• Levonorgestrel emergency contraceptive Consumer Information (Cerner Multum)
• Levonorgestrel intrauterine system Consumer Information (Cerner Multum)
• Levonorgestrel Advanced Consumer Information (Micromedex)
• Levonorgestrel Intrauterine Advanced Consumer Information (Micromedex)